Notably, mRNA expression levels of SP100 family members were consistently elevated in nine cancer tissues, including PAAD, cholangiocarcinoma (CHOL), and stomach adenocarcinoma (STAD), when compared to their respective noncancerous counterparts. The gene discussed is SP100; the disease is cholangiocarcinoma.